Sep 11, 2026
Korea Electric Power Stock Rises Friday: What’s Going On?

Shares of Korea Electric Power Corp. (NYSE:KEP) are trading higher Friday afternoon, as U.S.-listed South Korean equities rally on reports that Seoul and Washington are finalizing a landmark energy investment agreement exceeding $100 billion. Here’s what investors need to know.…

Sep 11, 2026
Seagate Stock Drops Friday: What’s Going On?

Shares of Seagate Technology Holdings PLC (NASDAQ:STX) are trading lower Friday afternoon as broader semiconductor and storage equities face selling pressure in the wake of an AI algorithmic efficiency breakthrough. Seagate Technology Hldgs stock is feeling bearish pressure. What’s weighing…

Sep 11, 2026
Stock of the Day: Is This the Top for Skyworks?

Skyworks Solutions, Inc. (NASDAQ:SWKS) is moving higher Friday. But that may not be the case for long. The shares are extremely overbought. They are also close to a resistance level. These can be bearish dynamics. This is why Skyworks is the…

Sep 11, 2026
Western Digital Stock Slips Friday: What’s Happening?

Shares of Western Digital Corp. (NASDAQ:WDC) are trading lower Friday afternoon as storage and semiconductor equities faced broad-based selling following a software efficiency breakthrough from AI developer DeepSeek. Here’s what investors need to know. Western Digital shares are experiencing downward…

Sep 11, 2026
SanDisk Stock Drops Friday Afternoon: What’s Driving the Action?

Shares of SanDisk Corp. (NASDAQ:SNDK) are trading lower Friday afternoon as sector-wide software efficiency concerns weigh on storage and memory equities. SanDisk stock is among today’s weakest performers. Why are SNDK shares down? DeepSeek V4.1 Flash Architecture Triggers Memory Demand…

Sep 11, 2026
Why Is American Airlines Stock Surging on Friday?

American Airlines Group Inc. (NYSE:AAL) stock traded higher on Friday, alongside a broader market rally. The upward movement followed a relief pullback in crude oil prices, which fell below $100 a barrel. The Nasdaq is up 1.15% while the S&P…

Sep 11, 2026
Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In

On Friday, the U.S. Food and Drug Administration (FDA) extended the review period for Exelixis Inc.‘s (NASDAQ:EXEL) new drug application (NDA) for zanzalintinib, in combination with atezolizumab, for metastatic colorectal cancer by three months. • Exelixis stock is under selling pressure.…